MAPT and Alzheimer disease: Lesser lipophilicity of the new tracer (logP = 2.3) results from the substitution of pyridine at 2-aryl group for benzene, imparts lower nonspecific binding to white matter along with a higher affinity for AD tau compared with [18F]THK-5117 (Figure 3d), and higher selectivity for tau over Aβ.